GLP-1 peptides (MidaSol Therapeutics)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameGLP-1 peptides (MidaSol Therapeutics)
Drug Alias NameGLP-1 peptides (Aquestive Therapeutics/Midatech)GLP-1 peptides (MonoSol/Midatech)MidaForm GLP-1
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiodexa Pharmaceuticals PLCAquestive Therapeutics Inc +[3] 
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A